Plastic Products · Founded 1983 · www.kingfaindia.com · BSE 524019 · NSE KINGFA · ISIN INE473D01015
No Notes Added Yet
Business
Kingfa Science & Technology (India) Ltd. is engaged in the manufacturing and sale of modified plastic compounds. The company produces a range of engineering plastic compounds, including polypropylenes (PP), nylons (PA), polycarbonates (PC), and blends, which are enhanced with various properties like high strength, heat resistance, flame retardancy, and impact resistance. These specialized compounds serve as critical raw materials for a diverse set of industries. The company makes money by selling these value-added modified plastic compounds to manufacturers across automotive, electrical & electronics, home appliances, construction, medical equipment, and other industrial sectors. It operates as a business-to-business (B2B) supplier.
Revenue Mix
Kingfa India primarily operates within a single business segment: the manufacturing and sale of modified plastic compounds. While it serves a variety of end-user industries (automotive, electrical & electronics, consumer durables, etc.), its revenue is derived from the sales of a unified product category of engineered plastics. Specific revenue contribution percentages from different end-user industries or product types are not typically segmented in its public reporting but are diversified across industrial applications.
Industry
The company operates in the specialty and modified plastics industry in India, which is a sub-segment of the broader plastic products sector. This industry is characterized by high technical requirements, continuous innovation, and strong linkages with other manufacturing sectors. Kingfa India is a subsidiary of Kingfa Science & Technology Co. Ltd., China, which is a global leader in modified plastics. This parentage provides it with a strong competitive standing, leveraging global R&D, technological expertise, and an established reputation in the B2B space. It positions itself as a provider of high-performance and customized plastic solutions, competing with both domestic and international players operating in the Indian market.
MOAT
Kingfa India's primary competitive advantage stems from its association with its parent company, Kingfa Science & Technology Co. Ltd. (China). This provides:
Technological Prowess: Access to the parent's extensive R&D, advanced manufacturing processes, and patented technologies, enabling superior product quality and innovation.
Global Scale & Sourcing: Benefits from the parent's global raw material sourcing network, potentially leading to cost efficiencies and consistent supply.
Brand & Reputation: Leverages the global reputation of the Kingfa brand within the B2B modified plastics segment, instilling confidence in customers regarding product quality and reliability.
Customization Capabilities: Ability to offer highly customized solutions tailored to specific client needs, a critical factor in the specialty plastics market.
Growth Drivers
Growth in End-User Industries: Strong growth in India's automotive, electrical & electronics, consumer durable, and white goods manufacturing sectors drives demand for modified plastics.
Increasing Plastic Penetration: Greater adoption of engineered and modified plastics in new applications and as substitutes for traditional materials (like metal) due to their lightweight, durability, and cost-effectiveness.
'Make in India' Initiative: Government focus on boosting domestic manufacturing can lead to increased demand for locally produced modified plastics.
Technological Advancements: Continuous product innovation and development of higher-performance, eco-friendly, or specialized plastic compounds for niche applications.
Import Substitution: Growing demand for domestically manufactured modified plastics to reduce reliance on imports.
Risks
Raw Material Price Volatility: Key raw materials (polymers, additives) are derivatives of crude oil, making the company susceptible to fluctuations in global crude oil prices and petrochemical markets.
Intense Competition: The modified plastics market in India is competitive, with both domestic and international players vying for market share, potentially impacting pricing power and margins.
Economic Slowdown: A downturn in the broader economy or specific end-user industries (e.g., automotive) can negatively impact demand for its products.
Foreign Exchange Fluctuations: Reliance on imported raw materials or technology can expose the company to adverse movements in foreign currency exchange rates.
Regulatory Changes: Evolving environmental regulations concerning plastic use and disposal could impact operations, product formulations, and compliance costs.
Management & Ownership
Kingfa Science & Technology (India) Ltd. is promoted by Kingfa Science & Technology Co. Ltd. of China, which holds a significant majority stake (typically over 70%). The management team comprises professionals with experience in the specialty chemicals and plastics industry. The strong ownership by a global leader ensures access to best practices, technological guidance, and potentially robust governance standards aligned with its parent company's global operations. The operational management is typically overseen by a mix of local talent and representatives from the parent company, ensuring strategic alignment and technical expertise.
Outlook
Kingfa India is well-positioned to benefit from India's robust manufacturing growth and increasing demand for high-performance engineered plastics. Its strong parentage provides a significant competitive edge in terms of technology, R&D, and quality, allowing it to cater to diverse and demanding industries. The "Make in India" initiative and the ongoing trend of plasticization across various sectors offer substantial growth avenues. However, the company faces inherent risks from volatile raw material prices, intense market competition, and potential slowdowns in key end-user industries. Managing these external factors while leveraging its technological strengths and customization capabilities will be crucial for sustained performance. The outlook remains cautiously optimistic, contingent on economic stability and effective cost management amidst competitive pressures.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
| #(Fig in Cr.) | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 394 | 404 | 416 | 418 | 440 | 470 | 462 | 466 | 489 | 578 |
| Other Income | 2 | 2 | 2 | 1 | 5 | 2 | 4 | 3 | 7 | 7 |
| Total Income | 396 | 406 | 418 | 419 | 445 | 471 | 466 | 468 | 497 | 586 |
| Total Expenditure | 357 | 354 | 359 | 362 | 389 | 409 | 404 | 405 | 428 | 497 |
| Operating Profit | 39 | 52 | 59 | 57 | 56 | 62 | 62 | 63 | 69 | 88 |
| Interest | 1 | 2 | 1 | 1 | 1 | 3 | 1 | 1 | 1 | 1 |
| Depreciation | 5 | 5 | 5 | 5 | 5 | 6 | 6 | 7 | 7 | 8 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 32 | 45 | 52 | 50 | 49 | 54 | 54 | 55 | 61 | 80 |
| Provision for Tax | 8 | 12 | 13 | 13 | 15 | 12 | 14 | 14 | 16 | 21 |
| Profit After Tax | 24 | 34 | 39 | 37 | 35 | 42 | 40 | 41 | 45 | 59 |
| Adjustments | -0 | -0 | 0 | -0 | 0 | 0 | 0 | 0 | -0 | -0 |
| Profit After Adjustments | 24 | 34 | 39 | 37 | 35 | 42 | 40 | 41 | 45 | 59 |
| Adjusted Earnings Per Share | 20.1 | 27.7 | 32.3 | 30.8 | 28.6 | 34.6 | 32.9 | 30.4 | 33.3 | 43.6 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 219 | 314 | 427 | 602 | 702 | 742 | 627 | 1048 | 1404 | 1488 | 1745 | 1995 |
| Other Income | 0 | 1 | 4 | 6 | 4 | 3 | 10 | 1 | 2 | 3 | 9 | 21 |
| Total Income | 219 | 315 | 431 | 607 | 706 | 744 | 638 | 1049 | 1406 | 1491 | 1754 | 2017 |
| Total Expenditure | 212 | 288 | 408 | 560 | 666 | 698 | 612 | 966 | 1276 | 1303 | 1520 | 1734 |
| Operating Profit | 7 | 28 | 23 | 47 | 40 | 46 | 26 | 83 | 130 | 188 | 234 | 282 |
| Interest | 8 | 7 | 2 | 2 | 2 | 4 | 3 | 5 | 7 | 6 | 7 | 4 |
| Depreciation | 3 | 3 | 3 | 6 | 8 | 9 | 11 | 13 | 14 | 18 | 22 | 28 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -23 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -5 | 17 | 18 | 39 | 29 | 33 | 12 | 41 | 110 | 164 | 206 | 250 |
| Provision for Tax | -2 | 7 | 5 | 14 | 10 | 9 | 7 | 11 | 28 | 42 | 53 | 65 |
| Profit After Tax | -3 | 11 | 12 | 25 | 19 | 25 | 5 | 31 | 81 | 123 | 153 | 185 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | -3 | 11 | 12 | 25 | 19 | 25 | 5 | 31 | 81 | 123 | 153 | 185 |
| Adjusted Earnings Per Share | -4.4 | 10.5 | 12.3 | 20.3 | 15.7 | 20.3 | 4.4 | 25.3 | 67.2 | 101.2 | 126.2 | 140.2 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 17% | 19% | 19% | 23% |
| Operating Profit CAGR | 24% | 41% | 38% | 42% |
| PAT CAGR | 24% | 70% | 44% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 72% | 41% | 37% | 22% |
| ROE Average | 23% | 22% | 15% | 9% |
| ROCE Average | 31% | 29% | 20% | 15% |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 8 | 119 | 244 | 305 | 324 | 349 | 354 | 385 | 466 | 589 | 729 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 15 | 16 | 16 | 16 | 17 | 18 | 24 | 17 | 0 | 0 | 0 |
| Other Non-Current Liabilities | -4 | 0 | 3 | 5 | 4 | 2 | 8 | 8 | 5 | 4 | 5 |
| Total Current Liabilities | 101 | 95 | 142 | 160 | 206 | 227 | 284 | 471 | 539 | 402 | 422 |
| Total Liabilities | 120 | 230 | 405 | 485 | 551 | 596 | 671 | 880 | 1010 | 994 | 1156 |
| Fixed Assets | 25 | 29 | 76 | 88 | 85 | 107 | 129 | 126 | 123 | 252 | 244 |
| Other Non-Current Assets | 2 | 43 | 13 | 9 | 94 | 128 | 136 | 142 | 149 | 17 | 58 |
| Total Current Assets | 93 | 158 | 316 | 388 | 372 | 362 | 407 | 612 | 738 | 725 | 854 |
| Total Assets | 120 | 230 | 405 | 485 | 551 | 596 | 671 | 880 | 1010 | 994 | 1156 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 0 | 0 | 2 | 1 | 1 | 13 | 2 | 4 | 20 | -9 | 0 |
| Cash Flow from Operating Activities | -1 | 19 | -119 | -116 | 96 | 30 | -2 | 38 | 27 | 16 | 60 |
| Cash Flow from Investing Activities | -4 | -47 | -18 | -6 | -77 | -63 | -14 | -19 | -24 | 2 | -30 |
| Cash Flow from Financing Activities | 5 | 34 | 137 | 162 | -7 | 22 | 17 | -14 | -21 | -8 | -7 |
| Net Cash Inflow / Outflow | 0 | 6 | -1 | 40 | 12 | -11 | 1 | 5 | -18 | 10 | 23 |
| Closing Cash & Cash Equivalent | 0 | 7 | 1 | 41 | 13 | 2 | 4 | 9 | 2 | 0 | 23 |
| # | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | -4.42 | 10.45 | 12.27 | 20.35 | 15.73 | 20.33 | 4.39 | 25.29 | 67.22 | 101.17 | 126.22 |
| CEPS(Rs) | 0.14 | 13.29 | 15.29 | 25.48 | 22.35 | 27.72 | 13.31 | 36 | 78.9 | 116.35 | 144.15 |
| DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10 | 0 |
| Book NAV/Share(Rs) | 11.87 | 115.56 | 129.83 | 252.09 | 267.94 | 287.84 | 292.29 | 317.57 | 384.78 | 486 | 601.63 |
| Core EBITDA Margin(%) | 2.62 | 7.48 | 4 | 6.67 | 5.02 | 5.84 | 2.47 | 7.82 | 8.95 | 12.25 | 12.75 |
| EBIT Margin(%) | 1.39 | 6.91 | 4.11 | 6.58 | 4.5 | 4.98 | 2.42 | 4.45 | 8.12 | 11.24 | 12.05 |
| Pre Tax Margin(%) | -1.9 | 4.88 | 3.66 | 6.25 | 4.17 | 4.5 | 1.89 | 3.95 | 7.66 | 10.87 | 11.68 |
| PAT Margin (%) | -1.23 | 3.03 | 2.57 | 3.99 | 2.72 | 3.32 | 0.85 | 2.92 | 5.69 | 8.11 | 8.66 |
| Cash Profit Margin (%) | 0.04 | 3.86 | 3.2 | 5 | 3.86 | 4.53 | 2.57 | 4.16 | 6.68 | 9.32 | 9.89 |
| ROA(%) | -2.73 | 6.16 | 3.91 | 5.54 | 3.68 | 4.29 | 0.84 | 3.95 | 8.61 | 12.22 | 14.22 |
| ROE(%) | -31.12 | 16.93 | 9.9 | 11.29 | 6.05 | 7.31 | 1.51 | 8.3 | 19.14 | 23.24 | 23.21 |
| ROCE(%) | 4.38 | 22.47 | 9.44 | 13.27 | 9.46 | 10.04 | 3.72 | 11.02 | 24.98 | 30.26 | 30.7 |
| Receivable days | 76.17 | 72.38 | 81.19 | 91.8 | 101.62 | 100 | 118.9 | 86.17 | 81.75 | 92.02 | 87.92 |
| Inventory Days | 40.62 | 46.79 | 48.44 | 54.6 | 56.83 | 52.58 | 73.92 | 70.35 | 70.18 | 64.15 | 56.18 |
| Payable days | 64.19 | 89.33 | 98.65 | 93.42 | 104.98 | 115.83 | 142.35 | 136.36 | 147.25 | 129.81 | 94.27 |
| PER(x) | 0 | 52.4 | 62.78 | 43.25 | 42.31 | 18.19 | 132.75 | 50.1 | 19.74 | 19.38 | 23.46 |
| Price/Book(x) | 19.03 | 4.74 | 5.93 | 3.49 | 2.48 | 1.28 | 2 | 3.99 | 3.45 | 4.03 | 4.92 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.51 | 0 |
| EV/Net Sales(x) | 1.05 | 1.83 | 1.68 | 1.69 | 1.1 | 0.63 | 1.19 | 1.48 | 1.15 | 1.61 | 2.06 |
| EV/Core EBITDA(x) | 35.02 | 20.89 | 31.24 | 21.68 | 19.43 | 10.25 | 28.87 | 18.66 | 12.44 | 12.75 | 15.36 |
| Net Sales Growth(%) | 23.04 | 43.59 | 35.95 | 40.86 | 16.6 | 5.7 | -15.41 | 67.07 | 33.95 | 5.99 | 17.27 |
| EBIT Growth(%) | 160.19 | 614.97 | -19.23 | 104.53 | -22.23 | 16.76 | -58.91 | 207.59 | 149.02 | 46.23 | 25.28 |
| PAT Growth(%) | 64.11 | 455 | 14.85 | 98.66 | -22.67 | 29.19 | -78.38 | 475.62 | 165.76 | 50.5 | 24.76 |
| EPS Growth(%) | 64.11 | 336.21 | 17.39 | 65.86 | -22.67 | 29.19 | -78.38 | 475.62 | 165.76 | 50.5 | 24.76 |
| Debt/Equity(x) | 9.24 | 0.13 | 0.32 | 0.07 | 0.05 | 0.13 | 0.19 | 0.11 | 0.08 | 0.05 | 0.05 |
| Current Ratio(x) | 0.92 | 1.67 | 2.22 | 2.43 | 1.81 | 1.59 | 1.43 | 1.3 | 1.37 | 1.8 | 2.02 |
| Quick Ratio(x) | 0.61 | 1.04 | 1.74 | 1.71 | 1.31 | 1.1 | 0.93 | 0.75 | 0.83 | 1.2 | 1.31 |
| Interest Cover(x) | 0.42 | 3.41 | 9.17 | 19.91 | 13.32 | 10.4 | 4.58 | 8.82 | 17.79 | 30.28 | 31.97 |
| Total Debt/Mcap(x) | 0.49 | 0.03 | 0.04 | 0.02 | 0.02 | 0.1 | 0.09 | 0.03 | 0.02 | 0.01 | 0.01 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 74.99 | 74.99 | 74.99 | 74.99 | 74.99 | 74.99 | 74.99 | 67.02 | 67.02 | 67.02 |
| FII | 6.36 | 6.33 | 6.33 | 6.36 | 6.35 | 6.35 | 6.34 | 7.78 | 7.73 | 7.76 |
| DII | 0 | 0 | 0 | 0.04 | 0 | 0.17 | 0.15 | 8.75 | 8.75 | 8.85 |
| Public | 18.64 | 18.68 | 18.67 | 18.61 | 18.66 | 18.48 | 18.52 | 16.46 | 16.5 | 16.37 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.91 | 0.91 | 0.91 | 0.91 | 0.91 | 0.91 | 0.91 | 0.91 | 0.91 | 0.91 |
| FII | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.11 | 0.1 | 0.11 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.12 | 0.12 | 0.12 |
| Public | 0.23 | 0.23 | 0.23 | 0.23 | 0.23 | 0.22 | 0.22 | 0.22 | 0.22 | 0.22 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1.21 | 1.21 | 1.21 | 1.21 | 1.21 | 1.21 | 1.21 | 1.36 | 1.36 | 1.36 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +17% | +19% | +19% | +23% |
| Operating Profit CAGR | +24% | +41% | +38% | +42% |
| PAT CAGR | +24% | +70% | +44% | — |
| Share Price CAGR | +72% | +41% | +37% | +22% |
| ROE Average | +23% | +22% | +15% | +9% |
| ROCE Average | +31% | +29% | +20% | +15% |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 74.99 | 74.99 | 74.99 | 74.99 | 74.99 | 74.99 | 74.99 | 67.02 | 67.02 | 67.02 |
| FII | 6.36 | 6.33 | 6.33 | 6.36 | 6.35 | 6.35 | 6.34 | 7.78 | 7.73 | 7.76 |
| DII | 0 | 0 | 0 | 0.04 | 0 | 0.17 | 0.15 | 8.75 | 8.75 | 8.85 |
| Public | 25.01 | 25.01 | 25.01 | 25.01 | 25.01 | 25.01 | 25.01 | 32.98 | 32.98 | 32.98 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.91 | 0.91 | 0.91 | 0.91 | 0.91 | 0.91 | 0.91 | 0.91 | 0.91 | 0.91 |
| FII | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.11 | 0.1 | 0.11 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.12 | 0.12 | 0.12 |
| Public | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.45 | 0.45 | 0.45 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1.21 | 1.21 | 1.21 | 1.21 | 1.21 | 1.21 | 1.21 | 1.36 | 1.36 | 1.36 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.